Study to Evaluate Imetelstat (GRN163L) in Participants With International Prognostic Scoring System (IPSS) Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Tymara Berry, MD
Geron Corporation
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
126 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Zas Cadix
Antwerp, Antwerpen, Belgium
- Zas Middelheim
Antwerp, Antwerpen, Belgium
- Gza Ziekenhuizen - Campus Sint
Wilrijk, Antwerpen, Belgium
- Az Sint-Jan Burgge-Oostende
Bruges, West-Vlaanderen, Belgium
- Az Groeninge
Kortrijk, West-Vlaanderen, Belgium
- Az Klina
Brasschaat, Belgium
- Universitair Ziekenhuis Gent
Ghent, Belgium
- Uz Leuven - Campus Gasthuisberg
Leuven, Belgium
- Tom Baker Cancer Centre
Calgary, Alberta, Canada
- University of Alberta Hospital - Hematology Research
Edmonton, Alberta, Canada
- the Ottawa Hospital
Ottawa, Ontario, Canada
- Princess Margaret Hospital
Toronto, Ontario, Canada
- Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada
- Jewish General Hospital
Montreal, Quebec, Canada
- Fakultni Nemocnice Brno
Brno, Brno-město, Czechia
- Fn Hradec Kralove
Hradec Králové, Hradec Králové, Czechia
- Fn Kralovske Vinohrady
Prague, Czechia
- Vseobecna Fakultni Nemocnice V Praze
Prague, Czechia
- Hopital de L'Archet
Nice, Alpes-Maritimes, France
- Chu Tours
Tours, Centre-Val de Loire, France
- Chu de Limoges, Hopital Dupuytren
Limoges, Haute-Vienne, France
- Chu de Grenoble - Hôpital Albe
La Tronche, Isère, France
- Chru Nancy Brabois
Vandœuvre-lès-Nancy, Meurthe-et-Moselle, France
- Ch Le Mans - Haematology
Le Mans, Sarthe, France
- Chu de Poitiers
Poitiers, Vienne, France
- Chu - Hã´pital Saint Louis - H
Paris, Île-de-France Region, France
- Centre Hospitalier Universitai
Angers, France
- Chru de Lille - Hopital Claude Huriez - Maladies Du Sang
Lille, France
- University Hospital Freiburg
Freiburg im Breisgau, Baden-Wurttemberg, Germany
- Fachärztliche Gemeinschaftspraxis Mit Schwerpunkt
Dresden, Saxony, Germany
- University Hospital Leipzig
Leipzig, Saxony, Germany
- Studienzentrum Für Hämatologie, Onkologie,diabetologie, Endoskopie Und Fußambulanz
Aschaffenburg, Germany
- University Hospital Bonn
Bonn, Germany
- Universitatsklinikum Carl Gustav Carcus Dresden
Dresden, Germany
- Universitätsklinikum Düsseldorf
Düsseldorf, Germany
- Johannes Gutenberg Universität
Mainz, Germany
- the Edith Wolfson Medical Center
H̱olon, Central District, Israel
- Meir Medical Center
Kfar Saba, Central District, Israel
- Kaplan Medical Center
Rehovot, Hagalil Saint, Israel
- Hadassah Medical Organization
Jerusalem, Jerusalem, Israel
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 12 Jan 2016
- Primary completion
- 13 Oct 2023
- Completion
- 13 Oct 2026
- Last update posted
- 5 Jan 2026
- Registered enrollment
- 289
- Registry id
- NCT02598661
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.